BSX Stock: Price, Earnings History and SEC Filings
Boston Scientific Corporation (BSX) last traded at $41.98, down 1.66% on the latest session and down 3.8% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $0.73 against an analyst estimate of $0.73, a beat of 0.0%.
$41.98 -1.66%
1 month-3.83%
52-week high$105.65
52-week low$39.57
Volume22.46M
ExchangeNYSE
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
BSX earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 28, 2026 | $0.73 | $0.73 | +0.00% |
| Jun 2026 | Jul 29, 2026 | $0.86 | $0.83 | +3.61% |
| Mar 2026 | Apr 22, 2026 | $0.80 | $0.80 | +0.00% |
| Dec 2025 | Feb 4, 2026 | $0.80 | $0.78 | +2.56% |
BSX beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
BSX financial history
Revenue
Free cash flow
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $20.1B | – | $3.7B | – | $1.94 |
| 2024 | $16.7B | – | $2.6B | – | $1.25 |
| 2023 | $14.2B | – | $1.8B | – | $1.07 |
| 2022 | $12.7B | – | $938M | – | $0.45 |
| 2021 | $11.9B | – | $1.3B | – | $0.69 |
| 2020 | $9.9B | – | $1.1B | – | $-0.08 |
| 2019 | $10.7B | – | $1.4B | – | $3.33 |
| 2018 | $9.8B | – | -$6M | – | $1.19 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for BSX
SEC filing data is not available right now. You can search for BSX on SEC EDGAR.
BSX news
- Intuitive Surgical vs. Boston Scientific: Which Stock Is a Better Buy Now?Oct 30, 2026 · finance.yahoo.com
- JNJ's MedTech Segment Disappoints in Q3: Will Growth Rebound in Q4?Oct 30, 2026 · finance.yahoo.com
- Buy, Sell, or Hold? Today’s Top Upgrades and Downgrades: Boston Scientific, DoorDash, GE Vernova, Honeywell Aerospace, Incyte. Intel, Reddit, Rivian Automotive, and MoreOct 30, 2026 · 247wallst.com
- New Strong Sell Stocks for October 30thOct 30, 2026 · finance.yahoo.com
- Cyberattack Fallout Could Be A Game Changer For Boston Scientific (BSX)Oct 29, 2026 · finance.yahoo.com
- Penumbra, Inc. Reports Third Quarter 2026 Financial ResultsOct 29, 2026 · finance.yahoo.com
- Boston Scientific (BSX) Wins FDA Clearances, Starts Elite AF Trial And Expands AI PushOct 29, 2026 · finance.yahoo.com
- Podcast: Boston Scientific on the growing importance of clinical evidence in cardiologyOct 29, 2026 · medicaldevice-network.com
About Boston Scientific Corporation
Boston Scientific Corporation (BSX) is a US-listed public company on NYSE.